Pro Web Services Launches AI-Powered Chatbot for Dental Clinics, First Integration at Westcoast Smile Dental 
uSmart Securities Initiates Coverage on Sunrise New Energy (EPOW.US) with a “Recommended” Rating and $10.07 Price Target 
VirPoint.com Unveils 2023 Financial Results and Launches AI Trading Suite at London Investor Summit Homeowners Can Increase Property Value by Refacing, Replacing, or Refinishing Their Kitchen Cabinets.
TORONTO, ON / ACCESSWIRE / February 20, 2021 / Kitchen renovations can improve property value…
Iterum Therapeutics to Present in Upcoming Investor Conferences
DUBLIN, Ireland and CHICAGO, Feb. 19, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical…
Recro to Report Financial Results for Fourth Quarter And Year-End 2020 on February 26
Conference Call and Webcast Scheduled for Friday, February 26 at 4:30 p.m. Eastern Time MALVERN,…
Tauriga Sciences Inc. Officially Launches Two New Product Offerings on its E-Commerce Platform (www.taurigum.com)
02_19_2021 Press Release image Image of Rainbow Bath Bomb Special The Company’s Two Newest Product…
Ayala Pharmaceuticals Announces $25 Million Strategic Financing
Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023 Funds Expected to Support…
Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment of HAE, at the AAAAI Annual Meeting
Single-dose treatment of PHA121 demonstrated effective bradykinin inhibition in healthy volunteers ZUG, Switzerland, Feb. 19,…
Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares
CHARLESTON, S.C., Feb. 19, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE…
Y-mAbs to Announce 2020 Financial and Operating Results on February 25, 2021
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Information expressed in the public domain by the Repharm Group is deceptive and contradictory
Today, on February 19, information has arrived in the public domain that the company from…
CEO of Longeveron Inc. to Present at the Intercontinental Summit on Aging & Gerontology
MIAMI, Feb. 19, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
WOBURN, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Intercept to Present at Upcoming Investor Conferences
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2020 Financial Results and Business Updates
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan
Chugai obtains exclusive development and marketing rights for AT-527 in Japan from Roche, who has…
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
GBT Announces Participation in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
CytomX Therapeutics Announces New Employment Inducement Grant
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb® Platform
Partnerships will use Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody…